Clinical Trial Update: Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing BIIB017 (peginterferon beta-1a) and Rebif (interferon beta-1a) in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• BIIB017 (peginterferon beta-1a) (peginterferon beta-1a)
• Rebif (interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED